BIOL Insider Trading Activity and SEC Form 4 Filings
BIOL insider trading summary
No open-market insider purchases or sales of Biolase, Inc (BIOL) have been reported on SEC Form 4 in the past 12 months.
Latest BIOL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 7, 2022 | Jonathan T Md Lord | Director | Sell | $3K (3,537 @ $0.75) |
| Dec 15, 2021 | Jonathan T Md Lord | Director | Sell | $4K (11,038 @ $0.38) |
| Nov 30, 2021 | John R Beaver | President & CEO | Buy | $32K (70,000 @ $0.45) |
| Aug 20, 2021 | John R Beaver | President & CEO | Buy | $21K (35,000 @ $0.61) |
| May 19, 2021 | John R Beaver | President & CEO | Buy | $30K (40,000 @ $0.75) |
| Dec 18, 2020 | Schuler Education Foundation | Insider | Sell | $53K (187,774 @ $0.28) |
| Dec 17, 2020 | Schuler Education Foundation | Insider | Sell | $160K (572,671 @ $0.28) |
| Dec 16, 2020 | Schuler Education Foundation | Insider | Sell | $25K (90,575 @ $0.28) |
| Dec 4, 2020 | Schuler Education Foundation | Insider | Sell | $360K (1,200,000 @ $0.30) |
| Nov 30, 2020 | Schuler Education Foundation | Insider | Sell | $335K (1,115,000 @ $0.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.